Please assess the completion status of the following clinical trial:

Trial Title: Adductor Canal Blockade vs Femoral Nerve Blockade on Muscle Strength, Mobility and Pain After TKA

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* TKA within 72 hours and VAS\>60 during 45 degrees active flexion of the knee despite conventional pain medication~* informed consent~* ASA 1-3~* BMI 18-40~Exclusion Criteria:~* Unable to communicate in Danish~* Allergic reactions toward ropivacaine~* Alcohol and or drug abuse~* Unable to cooperate~* Known sensory disturbances in the lower limbs

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Active FNB, placebo ACB (Type: EXPERIMENTAL): FNB with 30 ml of ropivacaine 0,2% and ACB with 30 ml of placebo (saline). The ACB will be performed just prior to the FNB. The blockades will be performed just after obtaining the baseline values (outcome measures) at time 0.
- Active ACB, placebo FNB (Type: EXPERIMENTAL): ACB with 30 ml of ropivacaine 0,2% and FNB with 30 ml of placebo (saline.The ACB will be performed just prior to the FNB. The blockades will be performed just after obtaining the baseline values (outcome measures) at time 0.

Based on this trial design, predict the completion outcome and termination type (if applicable).